Citation Impact
Citing Papers
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
2020 Standout
Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
2017
Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity
2020
Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells
2016
Breast cancer
2019 Standout
Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer
2016
Updated UK Recommendations for HER2 assessment in breast cancer
2014
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway
2018
Head and neck squamous cell carcinoma
2020 Standout
The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases
2017
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Triple-Negative Breast Cancer
2017
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
2016
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
Combinatorial Cancer Immunotherapies
2016
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer
2020
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
2013
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Natural and therapy-induced immunosurveillance in breast cancer
2015
The immune contexture in cancer prognosis and treatment
2017 Standout
The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
2016
Cancer-associated cachexia
2018 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The incidence and mortality of major cancers in China, 2012
2016
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Checkpoint inhibitors in breast cancer – Current status
2017
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
Deep learning in histopathology: the path to the clinic
2021 Standout
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
2016
A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma
2015
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Is Quality and Completeness of Reporting of Systematic Reviews and Meta-Analyses Published in High Impact Radiology Journals Associated with Citation Rates?
2015
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma
2014
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017
Deciphering the Roles of Innate Lymphoid Cells in Cancer
2019
MRI for breast cancer screening, diagnosis, and treatment
2011
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
2015
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Artificial intelligence in the interpretation of breast cancer on MRI
2019
Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
2015
Cancer statistics in China, 2015
2016 Standout
Immune Landscape of Breast Cancers
2018
Breast Cancer Treatment
2019 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Immune targeting in breast cancer.
2015
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
2015
Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer
2016
Impact of the 2013 A merican S ociety of C linical O ncology/C ollege of A merican P athologists guideline recommendations for human epidermal growth factor receptor 2 (HER 2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for HER 2 gene amplification by fluorescence in‐situ hybridization
2015
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Factors affecting number of citations: a comprehensive review of the literature
2016 Standout
Works of Xiaosong Chen being referenced
Role of chemokine receptor CXCR7 in bladder cancer progression
2012
The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy
2017
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study
2016
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
2012
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis
2016
FGF-2 Transcriptionally Down-Regulates the Expression of BNIP3L via PI3K/Akt/FoxO3a Signaling and Inhibits Necrosis and Mitochondrial Dysfunction Induced by High Concentrations of Hydrogen Peroxide in H9c2 Cells
2016
The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
2014
A novel long non-coding RNA-ARA: Adriamycin Resistance Associated
2013
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer
2016
Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer
2015
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
2012
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer
2013
Accuracy of MRI in Prediction of Pathologic Complete Remission in Breast Cancer After Preoperative Therapy: A Meta-Analysis
2010